Close Menu
Home » Tumor Sequencing May Pick Up Mutations Caused by Coexistent Blood Disorder

Tumor Sequencing May Pick Up Mutations Caused by Coexistent Blood Disorder

Jan 03, 2019
|
staff reporter

NEW YORK (GenomeWeb) – A new analysis suggests that a subset of patients with solid tumors may also suffer from blood conditions that introduce additional mutations into tumor sequencing data via infiltrating hematopoietic cells, particularly when matched germline sequencing data are not available. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

GEDmatch Under New Owners

Forensic genetic firm Verogen has bought the genetic genealogy site GEDmatch.

Generations of Bunnies

Researchers have 3D-printed plastic bunnies that encase the information needed to make more such bunnies in DNA, according to Discover magazine.

To Inform the Discussion

Dan Rather, the former CBS Evening News anchor and executive producer of a new documentary, writes at the Guardian that everyone needs to know about CRISPR.

PNAS Studies on ER+ Breast Cancer Target, Skin Condition Gene Repair, Uveoretinitis

In PNAS this week: analysis of FOXA1 upregulation in ER-positive breast cancer, gene editing to correct recessive dystrophic epidermolysis bullosa, and more.

Dec
17
Featured Webinar

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

Sponsored by
Thermo Fisher Scientific

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

Dec
19
Featured Webinar

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Sequencing

  1. Abu Dhabi Teams Up With BGI, Oxford Nanopore for Population Sequencing Project

  2. Forensic Genomics Firm Verogen Acquires Genealogy Website GEDmatch

  3. ASH Study Points to Distinct AML, MDS Subtypes Based on Genomic, Transcriptomic Analysis

  4. Adaptive Biotechnologies, AbbVie Partner on MRD Testing in Multiple Myeloma Drug Trials

  5. Veritas Genetics Halts US Operations, Lays Off More Than 30

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.